Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. NVO
NVO logo

NVO

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NVO News

Argosy Investors Q4 Moves: New Positions and Exits

2h agoseekingalpha

Short Squeeze Risk Intensifies for Stock

2h agoBenzinga

Oil Price Surge Drives Significant Stock Movements

4h agoCNBC

Novo Nordisk Plans Major Price Cuts for GLP-1 Drugs

5h agoFool

Hims & Hers Health Soars After Novo Nordisk Agreement

5h agoFool

Novo Nordisk Partners with Hims & Hers After Lawsuit Drop

6h agoFool

Hims & Hers Shares Surge 52% After Novo Nordisk Drops Patent Lawsuit

8h agostocktwits

Surging Oil Prices Amid Market Turmoil

8h agoCNBC

Novo Nordisk Drops Lawsuit Against Hims Over Patent Issues

8h agoNewsfilter

Hims & Hers Partners with Novo Nordisk for Weight Loss Drugs

9h agoseekingalpha

NASDAQ 100 Pre-Market Update: Key Movers

9h agoNASDAQ.COM

Oil Prices Surge, Boosting Oil Stocks Ahead of Market Open

9h agoCNBC

Novo Nordisk Drops Lawsuit Against Hims & Hers After Agreement

9h agoCNBC

Roche's New Drug Trial Misses Primary Goal

9h agoBenzinga

FDA's Makary Welcomes Hims' Decision to Cease Advertising Unapproved Compounded Drugs and Focus on FDA-Approved Products via New Partnership with Novo

9h agomoomoo

Novo Nordisk Partners with Hims & Hers for Weight-Loss Drug

10h agoBenzinga